7,053 Shares in Globe Life Inc. $GL Purchased by Bridgefront Capital LLC

Bridgefront Capital LLC acquired a new stake in Globe Life Inc. (NYSE:GL) during the 3rd quarter, HoldingsChannel.com reports. The fund acquired 7,053 shares of the company’s stock, valued at approximately $1,008,000.

Other large investors also recently bought and sold shares of the company. California Public Employees Retirement System boosted its stake in Globe Life by 4.7% during the third quarter. California Public Employees Retirement System now owns 170,994 shares of the company’s stock worth $24,447,000 after buying an additional 7,671 shares during the period. Bank of America Corp DE raised its stake in shares of Globe Life by 10.0% in the 3rd quarter. Bank of America Corp DE now owns 721,176 shares of the company’s stock valued at $103,106,000 after acquiring an additional 65,334 shares during the period. Bank of Nova Scotia lifted its holdings in shares of Globe Life by 37.8% in the 3rd quarter. Bank of Nova Scotia now owns 91,634 shares of the company’s stock worth $13,101,000 after acquiring an additional 25,120 shares during the last quarter. Boothbay Fund Management LLC acquired a new position in shares of Globe Life in the 3rd quarter worth approximately $416,000. Finally, Aquatic Capital Management LLC boosted its position in shares of Globe Life by 42.9% during the 3rd quarter. Aquatic Capital Management LLC now owns 11,297 shares of the company’s stock worth $1,615,000 after purchasing an additional 3,393 shares during the period. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Stock Performance

Shares of GL stock opened at $138.51 on Friday. The firm has a 50 day moving average of $142.07 and a two-hundred day moving average of $139.01. The stock has a market capitalization of $10.89 billion, a PE ratio of 9.84 and a beta of 0.46. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.39. Globe Life Inc. has a 52 week low of $109.38 and a 52 week high of $152.71.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The company had revenue of $1.52 billion for the quarter, compared to analysts’ expectations of $1.53 billion. Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The firm’s revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the company posted $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, research analysts predict that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Thursday, April 2nd. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. Globe Life’s payout ratio is presently 9.38%.

Insider Activity at Globe Life

In other news, CMO Jennifer Allison Haworth sold 10,000 shares of the business’s stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $143.14, for a total transaction of $1,431,400.00. Following the completion of the transaction, the chief marketing officer directly owned 17,479 shares of the company’s stock, valued at approximately $2,501,944.06. The trade was a 36.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Frank M. Svoboda sold 12,500 shares of the company’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the sale, the chief executive officer owned 35,868 shares in the company, valued at $5,192,969.04. The trade was a 25.84% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 92,186 shares of company stock worth $13,358,379 over the last quarter. 1.51% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

GL has been the subject of several research reports. Wells Fargo & Company lifted their target price on shares of Globe Life from $170.00 to $171.00 and gave the company an “overweight” rating in a report on Wednesday, February 25th. TD Cowen restated a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Weiss Ratings raised Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, February 13th. Morgan Stanley reiterated an “overweight” rating and issued a $176.00 price objective on shares of Globe Life in a report on Monday, December 15th. Finally, JPMorgan Chase & Co. raised their target price on Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Eight equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $171.33.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.